Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Yкраїнський (UK)
Przejdź do strony domowej biblioteki Centralna Biblioteka Wojskowa Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaCentralna Biblioteka Wojskowa

Wyszukujesz frazę "pharmaceutical industry;" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-15 z 51
Tytuł:
Etyczne wyzwania współpracy pomiędzy lekarzami a przemysłem farmaceutycznym
Autorzy:
Makowska, Marta
Powiązania:
https://bibliotekanauki.pl/articles/653060.pdf
Data publikacji:
2011
Wydawca:
Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
Tematy:
physicians
pharmaceutical industry
business ethics
Źródło:
Annales. Etyka w Życiu Gospodarczym; 2011, 14, 2
1899-2226
2353-4869
Pojawia się w:
Annales. Etyka w Życiu Gospodarczym
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Controversial advertising of medicines. A comparison between Poland and the United States
Autorzy:
Makowska, Marta
Powiązania:
https://bibliotekanauki.pl/articles/653027.pdf
Data publikacji:
2018
Wydawca:
Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
Tematy:
pharmaceutical industry
advertisement
drugs
law
ethics
Opis:
For many years, the subject of aggressive marketing campaigns conducted by pharmaceutical companies has been raised in Poland. Drug ads are everywhere, on television, the radio, magazines and on the Internet. Therefore, it is extremely important is to ensure both their legal and ethical dimension. This article will present the differences between direct-to-consumer advertising of medicines in Poland and in the US. The dissimilarities result mainly from differences in legislation. In Poland, the law is much stricter than in the US. For example, in the United States companies are allowed to advertise prescription drugs directly to patients. In the whole of the European Union, and thus in Poland, it is strictly prohibited. The article will also present other regulations existing in Poland and in the United States and it will compare them. It will offer examples of violations of the law and ethics in the advertising of medicine in both countries. Lastly, it will briefly outline the negative consequences of unacceptable pharmaceutical marketing.
Źródło:
Annales. Etyka w Życiu Gospodarczym; 2018, 21, 5; 67-79
1899-2226
2353-4869
Pojawia się w:
Annales. Etyka w Życiu Gospodarczym
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Contemporary Trends in the Development of the Pharmaceutical Industry in the World
Autorzy:
Dorocki, Sławomir
Powiązania:
https://bibliotekanauki.pl/articles/439225.pdf
Data publikacji:
2014
Wydawca:
Uniwersytet Pedagogiczny im. Komisji Edukacji Narodowej w Krakowie
Tematy:
BRIC;
clinical trials;
pharmaceutical industry;
relocation;
USA
Opis:
The pharmaceutical industry remains today a prominent high-technology sector of the economy,and consistently maintains its competitiveness on the world market at a very high level. Similarly to aircraft and spacecraft manufacturing and the electro-energy industry, pharmaceutical industry belongs to a group of innovative high-technology industries, which are based on scientific research results processed for industrial activities. The purpose of this study is to present and analyse global trends currently observed in the pharmaceutical industry in the world. In an era of increasing globalization, new prime movers of the development of the pharmaceutical industry are the countries from peripheralregions, mainly members of the BRICS group. For this reason, this article focuses on the emerging Asian and Latin American markets, next to the United States and countries of Western Europe. At the beginning of the twenty-first century, Brazil and China deemed the stimulation of the pharmaceutical industry one of the prime determinants of their future economic development. The following paper at first presents characteristics of the pharmaceutical industry products: innovative and generic medicines, medications available without prescription, biological agents, biosimilars and pharmaceutical substrates. Furthermore, the author specifies the properties and rates the dynamics of changes that are taking place in the global pharmaceutical market, while explaining the specifics of the relocation of the pharmaceutical industry. By comparing the number of publications in the field of pharmacy in selected countries of the world, the author confirmed the increasing importance of this industry on the global economy. In the last part of the article, the author presents the structure, number and distribution of clinical trials on a global scale. To illustrate the trends currently taking place in the development of the pharmaceutical industry, the author used raw statistical data in the field of pharmacology and literature on the subject.
Źródło:
Prace Komisji Geografii Przemysłu Polskiego Towarzystwa Geograficznego; 2014, 25; 108-131
2080-1653
Pojawia się w:
Prace Komisji Geografii Przemysłu Polskiego Towarzystwa Geograficznego
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Etyczne wyzwania w przemyśle farmaceutycznym. Zarys problematyki
Ethical Challenges in the Pharmaceutical Industry. An Outline of Issues
Autorzy:
Kaczmarek, Emilia
Powiązania:
https://bibliotekanauki.pl/articles/965064.pdf
Data publikacji:
2015-09
Wydawca:
Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
Tematy:
pharmaceutical industry
bioethics
conflict of interests
pharmaceuticalization
Opis:
The goal of the text is to show which actions of the modern pharmaceutical industry are morally controversial. There are several burning issues that we need to face on this field, such as: How to deal with the conflict of interests within the medicine? How to mark the vanishing boundaries between information and advertisement concerning the pharmaceutical education? How does the drug advertisement lead to the pharmaceuticalization of society? In the text all of these problems will be briefly analysed. The article has an introductory character, it may serve as an overview of the burning issues in the pharmaceutical industry ethics – all questions that are posed in the text need further examination.
Źródło:
Annales. Etyka w Życiu Gospodarczym; 2015, 18, 3
1899-2226
2353-4869
Pojawia się w:
Annales. Etyka w Życiu Gospodarczym
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Znaczenie „przejrzystości” w relacjach lekarzy z firmami farmaceutycznymi
The Importance of ‘Disclosure’ in Relationships between Physicians and Pharmaceutical Companies
Autorzy:
Makowska, Marta
Jasiński, Łukasz
Powiązania:
https://bibliotekanauki.pl/articles/653000.pdf
Data publikacji:
2017
Wydawca:
Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
Tematy:
-
conflict of interest
disclosure
ethical standard
pharmaceutical industry
Opis:
The article raises issues of transparency in relationships between doctors and drug manufacturers. It indicates how important it is as a way for physicians and the pharmaceutical industry to regain public trust. The manuscript will define the concept of disclosure. It will discuss in detail The Physician Payment Sunshine Act from the U.S., which imposes a legal obligation on pharmaceutical companies to disclose their relationships with doctors and university hospitals. The article will also show the diverse regulation of disclosure in different countries of the European Union. The situation in Poland will be also described. In the summary, there will be a discussion about the importance of disclosure for patients and the advantages and disadvantages of such regulations for physicians and drug manufacturers.
-
Źródło:
Annales. Etyka w Życiu Gospodarczym; 2017, 20, 1
1899-2226
2353-4869
Pojawia się w:
Annales. Etyka w Życiu Gospodarczym
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Edward Idzi Gobiec (1886–1958) — farmaceuta dorpatczyk, pionier polskiego przemysłu zielarskiego i farmaceutycznego
Edward Gobiec (1886–1958) — Pharmacist, Pioneer of Polish Pharmaceutical and Herbal Industry
Autorzy:
Brzezińska, Jadwiga
Powiązania:
https://bibliotekanauki.pl/articles/972566.pdf
Data publikacji:
2013
Wydawca:
Polskie Towarzystwo Historii Filozofii i Medycyny
Tematy:
przemysł zielarski i farmaceutyczny
herbal and pharmaceutical industry
Opis:
Edward Gobiec, urodzony w Warszawie, od dziecka miał zamiłowanie do nauk przyrodniczych. Dlatego obrał sobie zawód aptekarza. Po studiach farmaceutycznych w Dorpacie/Jurewie/Tartu (1909–1911) wrócił do Warszawy. Przez pewien czas pracował w aptece. Potem założył hurtownię farmaceutyczną. Następnie sprzedał ją i zaczął produkować w laboratorium soki roślinne, syropy i różne specyfiki roślinne na podstawie receptury opracowanej przez prof. farmakognozji Jana Muszyńskiego. Swą produkcję oparł na własnej plantacji roślin lekarskich. Jego podręcznik „Vademecum lecznictwa roślinnego” znajdował się w każdej aptece w Polsce.
Edward Gobiec, born in Warsaw, from his early childhood was interested in natural sciences. That is why he became a pharmacist. After graduating from pharmacy studies at the University of Dorpat/Juriew/Tartu (1909– –1911) he came back to Warsaw. For some time he worked at a pharmacy and later set up a pharmaceutical warehouse. After selling it he started to produce plant juices, syrups, and various plant medicines using the prescription of a professor of pharmacognosy Jan Muszyński. The production was based on his own medical plants plantation. His book “Vademecum of plant medicine” could be found in every pharmacy in Poland.
Źródło:
Archiwum Historii i Filozofii Medycyny; 2013, 76/1; 29-34
0860-1844
Pojawia się w:
Archiwum Historii i Filozofii Medycyny
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Jan Witold Gessner (1886–1953), dorpatczyk, kontynuator aptekarskich i przemysłowych tradycji „pharmacia elegans” ojca Edwarda Gessnera (1853–1907)
Jan Witold Gessner (1886–1953) Continuator of Industrial Traditions of His Father Edward Gessner (1853–1907)
Autorzy:
Brzezińska, Jadwiga
Powiązania:
https://bibliotekanauki.pl/articles/530581.pdf
Data publikacji:
2012
Wydawca:
Polskie Towarzystwo Historii Filozofii i Medycyny
Tematy:
przemysł farmaceutyczny
wytwórczość
zielarska
pharmaceutical industry
manufacturing
Herbal
Opis:
Edward Gessner był pionierem polskiego przemysłu farmaceutycznego. Zapoczątkował wyrób specyfi ków w pięknych opakowaniach. Jego syn Jan Witold Gessner ukończył studia farmacji na Uniwersytecie w Dorpacie/ Jurewie. Kontynuował produkcję przemysłową specyfi ków w laboratorium przy aptece, a potem w fabryce, którą założył. Jego fi rma wytwarzała w 1939 r. 151 specyfi ków, szczepionki i preparaty ziołowe.
Edward Gessner was a pioneer of Polish pharmaceutical industry. It was him who started the production of medicines in beautiful containers. His son Jan Witold graduated from University of Dorpat (Jurew). He continued the industrial production of medicines in a laboratory next to the pharmacy, and later in the factory, which he founded. He was active in community life. In March 1950 year his laboratory, which he rebuilt from the ruins in Warsaw, and on 8th January 1951 year also the pharmacy were nationalized.
Źródło:
Archiwum Historii i Filozofii Medycyny; 2012, 75/2; 35-47
0860-1844
Pojawia się w:
Archiwum Historii i Filozofii Medycyny
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The importance of “disclosure” in relationships between physicians and pharmaceutical companies
Autorzy:
Makowska, Marta
Jasiński, Łukasz
Powiązania:
https://bibliotekanauki.pl/articles/653029.pdf
Data publikacji:
2018
Wydawca:
Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
Tematy:
conflict of interest
disclosure
ethical standard
pharmaceutical industry
Opis:
The article raises issues of transparency in relationships between doctors and drug manufacturers. It indicates how important it is as a way for physicians and the pharmaceutical industry to regain public trust. The manuscript will define the concept of disclosure. It will discuss in detail The Physician Payment Sunshine Act from the U.S., which imposes a legal obligation on pharmaceutical companies to disclose their relationships with doctors and university hospitals. The article will also show the diverse regulation of disclosure in different countries of the European Union. The situation in Poland will be also described. In the summary, there will be a discussion about the importance of disclosure for patients and the advantages and disadvantages of such regulations for physicians and drug manufacturers.
Źródło:
Annales. Etyka w Życiu Gospodarczym; 2018, 21, 5; 81-94
1899-2226
2353-4869
Pojawia się w:
Annales. Etyka w Życiu Gospodarczym
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Rola śledztw dziennikarskich w kreowaniu etycznych standardów marketingu farmaceutycznego
Role of Investigations of Journalist in Creating Ethical Standards of Pharmaceutical Marketing
Autorzy:
Makowska, Marta
Powiązania:
https://bibliotekanauki.pl/articles/468660.pdf
Data publikacji:
2012
Wydawca:
Polska Akademia Nauk. Instytut Filozofii i Socjologii PAN
Tematy:
physicians
medical sales representatives
pharmaceutical industry
journalists
business ethics
Opis:
This article demonstrates that journalists and their publications influenced the rise of ethical standards of pharmaceutical marketing in Poland. Nowadays media perform a substantial role in creating and changing reality. In this article, investigations of Polish journalists concerning the relation of doctors with medical sales representatives are described. The author analyses Polish pharmaceutical law and existence of the self-regulation of ethical organizations of pharmaceutical companies and of doctors in Poland. It also presents the results of in-depth interviews with medical sales representatives and shows their opinion whether journalistic investigations and other disapproving publications in the media influenced their work and the functioning of their company. Before reporters started revealing possible reservations about the cooperation of physicians with industry representatives, this subject was largely neglected. Published press reports caused further examinations, and often led to the arrest of persons associated with corruption. It is possible that first journalistic, and then prosecutor’s investigations sharpened the the Polish pharmaceutical law of 2007.
Źródło:
Prakseologia; 2012, 152; 125-144
0079-4872
Pojawia się w:
Prakseologia
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Etyczne uregulowania kontaktów studentów medycyny z firmami farmaceutycznymi w Stanach Zjednoczonych
Ethical Regulation of Medical Students’ Interactions with the Pharmaceutical Industry in the United States
Autorzy:
Makowska, Marta
Powiązania:
https://bibliotekanauki.pl/articles/20311662.pdf
Data publikacji:
2014
Wydawca:
Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
Tematy:
pharmaceutical industry
medical education
conflict-of-intrest policies
business ethics
Opis:
The involvement of the pharmaceutical industry in medical education can be seen as something completely natural. Who better than the producer of the med-icine would know how the drug was developed, how the process of it being au-thorized for sale proceeded, and what the side effects of it are? Today in the United States, more and more colleges are implementing strong pharmaceutical conflict-of-interest policies. Interaction between students and medical school staff with these companies is undesirable, because they share marketing materi-als more often than honest data, and their representatives use various ways to influence these current and future physicians during their meetings. This article will describe research which shows what pharmaceutical mar-keting directed at students looks like in the USA – its character, frequency, and potential impact on future medical decisions. Also, ways of regulating interac-tion between medical schools, their staff and students and the pharmaceutical industry will be expressed. Guidelines of the Association of American Medical Colleges, the Institute of Medicine and the American Medical Student Associa-tion will be described. At the end, questions about their influence on reality and whether medical schools’ policies can be an effective barrier for pharmaceutical marketing on medical schools will be asked.
Źródło:
Annales. Etyka w Życiu Gospodarczym; 2014, 17, 3; 125-137
1899-2226
2353-4869
Pojawia się w:
Annales. Etyka w Życiu Gospodarczym
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Telegraph communication networks used by the Japanese pharmaceutical industry in 1901
Autorzy:
Amijima, Takashi
Powiązania:
https://bibliotekanauki.pl/articles/2138600.pdf
Data publikacji:
2019-08-04
Wydawca:
Uniwersytet Warszawski. Wydział Geografii i Studiów Regionalnych
Tematy:
Industrialization
regional formation
pharmaceutical industry
telegraph code
Japan
patent medicine
Opis:
This article examines how the communication network of the Japanese pharmaceutical industry operated around the turn of the century to create spatial interactions across the national medicine market during a period of intense industrialization. In 1901, pharmaceutical wholesalers in Osaka compiled The Telegraph Codebook of Pharmacies in Japan to facilitate national trade in medicine, although its use was restricted to only the 177 pharmacies that joined the Pharmaceutical Telegraph Communication Alliance. This alliance had close ties with wholesalers in Osaka and comprised national-level qualified chemists. The use of this communication network by telegraph enabled the integration and progression of the Japanese pharmaceutical market in the early 20th century; however, pharmacies also began to build diferent and layered communication networks that corresponded to their respective business styles. Findings indicate that pharmacies used diferent communication networks of diferent spatial scales, thereby operating regional specialization and national integration networks simultaneously.
Źródło:
Miscellanea Geographica. Regional Studies on Development; 2019, 23, 3; 144-151
0867-6046
2084-6118
Pojawia się w:
Miscellanea Geographica. Regional Studies on Development
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Indian Legal Framework in Shaping Patents Regime in the Healthcare Sector vis-à-vis Securing Right to Public Health
Autorzy:
Roy, Piyush
Chandani, Ridhima
Kulshrestha, Sony
Powiązania:
https://bibliotekanauki.pl/articles/44754035.pdf
Data publikacji:
2023-06-15
Wydawca:
Akademia Leona Koźmińskiego w Warszawie
Tematy:
patent
healthcare
right to health
pharmaceutical industry
global value chain
Opis:
The patents regime in healthcare sector and its tussle with right to public health is a long controversial saga. The crux of matter which is debated focuses upon providing patent rights that reduces the accessibility of cost-effective healthcare services, particularly in developing country. The counter point to this has remained that providing patent allows nurturing of research and development in the healthcare sector, which promotes the healthcare industry to take initiatives to tackle various health related problems and provide better treatment. According to the rival opinions presented in the aforesaid, the centre of the issue is health, therefore it is necessary to discuss the corresponding rights of citizens and duties of the government to make healthcare industry favourable.
Źródło:
Krytyka Prawa. Niezależne Studia nad Prawem; 2023, 15, 2; 98-110
2080-1084
2450-7938
Pojawia się w:
Krytyka Prawa. Niezależne Studia nad Prawem
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The characteristics of the current drug policies in India, Nepal and Bangladesh
Autorzy:
Sarowar, Mohammad Golam
Bhattarai, Nawaraj
Jain, Payal
Bochenek, Tomasz
Powiązania:
https://bibliotekanauki.pl/articles/635036.pdf
Data publikacji:
2008
Wydawca:
Uniwersytet Jagielloński. Wydawnictwo Uniwersytetu Jagiellońskiego
Tematy:
pharmaceutical policy, drug policy, pharmaceutical industry, access to drugs, health care reforms, Bangladesh, India, Nepal
Opis:
The current Indian national drug policy has its roots in two documents originated in the 70-ties and the 80-ties of the XX. century. Although the first National Drug Policy was declared in 1978, it has been revised thrice since then, in 1986, 1994 and 2002. Also, in 1986 another document on the Indian drug policy, titled “Measures for Rationalisation, Quality Control and Growth of Drugs and Pharmaceutical Industry in India” was evolved. The drug policy has been implemented under some legal acts related mainly to the fields of health care, family welfare, scientific research and development, and industry. It emerged from the findings of the Hathi Committee (a committee commissioned to study the operations of multinational drug companies vis-à-vis indigenous companies and public sector undertakings).
Źródło:
Zdrowie Publiczne i Zarządzanie; 2008, 6, 1-2
2084-2627
Pojawia się w:
Zdrowie Publiczne i Zarządzanie
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Biznes idzie do szkoły. Marketing farmaceutyczny skierowany do polskich i amerykańskich studentów medycyny
Business Goes to School. Polish and US medical students’ exposure to pharmaceutical industry marketing
Autorzy:
Makowska, Marta
Powiązania:
https://bibliotekanauki.pl/articles/469116.pdf
Data publikacji:
2015
Wydawca:
Polska Akademia Nauk. Instytut Filozofii i Socjologii PAN
Tematy:
studenci medycyny
marketing
przemysł farmaceutyczny
edukacja
medycyna
students
pharmaceutical industry
education
medicine
Opis:
Artykuł podejmuje problematykę współpracy przemysłu lekowego ze studentami medycyny oraz przedstawia wyniki badania ilościowego przeprowadzonego wśród studentów medycyny z Warszawskiego Uniwersytetu Medycznego i czterech szkół medycznych z Filadelfii w USA dotyczącego ich kontaktów z producentami leków. Badanie te pokazują, że w Polsce studenci medycyny spotykają się z większą ilością form marketingu farmaceutycznego niż amerykańscy, a ponadto otrzymują od nich słabszą edukację nt. relacji z przemysłem farmaceutycznym. Wyniki te powinny wzbudzić niepokój i chęć zmian w tej kwestii.
In world literature a lot is written about contacts of physicians with pharmaceutical industry, however less research are dealing with the cooperation of business with medical students. In Poland this problem have not been studied, yet. The article will discuss those issues and will show the results of the quantitative research conducted with the self-administered questionnaire amongst medical students from the Warsaw Medical University and four medical schools from Philadelphia in US. In Poland 52,5% of total number of medical students and in US 34,6% have participated at the lecture, seminars, presentation or other educational meeting organized by the pharmaceutical company. Among Polish respondents 49,1% and among American 21,4% have received a gift from pharmaceutical company. US students (41,0%) more often than Polish ones (37,7%) have talked with pharmaceutical representative about drugs, but Polish (10,0%) more often than American students (5,8%) have talked with reps about personal issues. All the problems connected with proper cooperation with industry such as: critical look at marketing materials from pharmaceutical companies; seeking the reliable information about drugs; methods of the manipulation and influence used by reps; ethical standards of the cooperation of physicians with pharmaceutical industry; legal standards of the cooperation of physicians with industry; revealing potential and existing conflicts of interest – were brought up statistically significant more rarely in Polish medical schools than in US medical education. Polish students more often have contact with different forms of pharmaceutical marketing than their US colleagues and weaker education concerning. Those results should arise concern and willingness of changes.
Źródło:
Prakseologia; 2015, 157/1; 121-143
0079-4872
Pojawia się w:
Prakseologia
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Kontrowersje związane z reklamowaniem leków Analiza porównawcza Polski i Stanów Zjednoczonych
Controversial Advertising of Medicines. A Comparison between Poland and the United States
Autorzy:
Makowska, Marta
Powiązania:
https://bibliotekanauki.pl/articles/965175.pdf
Data publikacji:
2016-09-15
Wydawca:
Uniwersytet Łódzki. Wydawnictwo Uniwersytetu Łódzkiego
Tematy:
pharmaceutical industry
advertisement
drugs
law
ethics
I18
M31
M38
Opis:
For many years, the subject of aggressive marketing campaigns conducted by pharmaceutical companies has been raised in Poland. Drug ads are everywhere, on television, the radio, magazines and on the Internet. Therefore, it is extremely important is to ensure both their legal and ethical dimension. In my article I will present the differences between direct-to-consumer advertising of medicines in Poland and in the US. The dissimilarities result mainly from differences in legislation. In Poland the law is much stricter than in the US. For example, in the United States companies are allowed to advertise prescription drugs directly to patients. In the whole of the European Union, and thus in Poland, it is strictly prohibited. The article will present other regulations existing in Poland and in the United States and it will compare them. It will show examples of violations of the law and ethics in the advertising of medicine in both countries. It will briefly outline the negative consequences of unacceptable pharmaceutical marketing.
Źródło:
Annales. Etyka w Życiu Gospodarczym; 2016, 19, 3
1899-2226
2353-4869
Pojawia się w:
Annales. Etyka w Życiu Gospodarczym
Dostawca treści:
Biblioteka Nauki
Artykuł
Wyświetlanie 1-15 z 51

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies